drugset / Trial / NCT01123070
TL011 in Severe, Active Rheumatoid Arthritis Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine the safety and pharmacology of TL011 in patients with severe rheumatoid arthritis.
Timeline
- Start
- 2010-02-05
- Primary completion
- 2012-04-23
- Completion
- 2012-04-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rituximab | Monoclonal antibody | — | — |
| Subject | TL011 | Unknown | — | — |